HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences.

Abstract
This study was performed in 2003-05 to determine the serological status of a sample of pregnant women as a preliminary study for the rubella vaccination programme. Out of 965 pregnant women attending health centres affiliated to Tehran University of Medical Sciences for prenatal care, the estimated rubella immunity rate was 91.1% (95% CI: 89.3%-92.9%) and the nonimmunity rate was 8.9% (95% CI: 7.1%-10.7%). The rubella immunity rate differed in different areas of Tehran but not significantly so. However, there was a significant difference in the level of rubella immunity by the number of persons per household and by age, but no significant relationship with economic status, occupation or level of education.
AuthorsF Majlessi, A Batebi, M Shariat, A Rahimi, T M Azad
JournalEastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit (East Mediterr Health J) 2008 May-Jun Vol. 14 Issue 3 Pg. 590-4 ISSN: 1020-3397 [Print] Egypt
PMID18720623 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
Topics
  • Academic Medical Centers
  • Adolescent
  • Adult
  • Age Distribution
  • Antibodies, Viral (blood)
  • Cross-Sectional Studies
  • Family Characteristics
  • Female
  • Humans
  • Immunity, Active (immunology)
  • Immunoglobulin G (blood)
  • Iran (epidemiology)
  • Middle Aged
  • Population Surveillance
  • Pregnancy
  • Pregnancy Complications, Infectious (blood, epidemiology, immunology, prevention & control)
  • Prenatal Care
  • Risk Assessment
  • Risk Factors
  • Rubella (blood, epidemiology, immunology, prevention & control)
  • Rubella virus (immunology)
  • Seroepidemiologic Studies
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: